The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival

References

• BesseBOlaussenKASoriaJCERCC1 and RRM1: ready for prime time?J Clin Oncol20133181050106023401439
   PubMed Web of Science ®Google Scholar
• FisherLASamsonLBesshoTRemoval of reactive oxygen species-induced 3′-blocked ends by XPF-ERCC1Chem Res Toxicol201124111876188122007867
   PubMed Web of Science ®Google Scholar
• McVeyMLeeSEMMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endingsTrends Genet2008241152953818809224
   PubMed Web of Science ®Google Scholar
• WangXZhaoJYangLPositive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancerMed Oncol201027248449019488864
   PubMed Web of Science ®Google Scholar
• CeppiPVolanteMNovelloSERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabineAnn Oncol200617121818182516980606
   PubMed Web of Science ®Google Scholar
• LordRVBrabenderJGandaraDLow ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancerClin Cancer Res2002872286229112114432
   PubMed Web of Science ®Google Scholar
• PitterleDMKimYCJolicoeurEMCaoYO’BriantKCBeplerGLung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1)Mamm Genome199910991692210441745
   PubMed Web of Science ®Google Scholar
• JordheimLPSèvePTrédanODumontetCThe ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancerLancet Oncol201112769370221163702
   PubMed Web of Science ®Google Scholar
• BeplerGKusmartsevaISharmaSRRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancerJ Clin Oncol200624294731473716966686
   PubMed Web of Science ®Google Scholar
• ReynoldsCObasajuCSchellMJRandomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerJ Clin Oncol200927345808581519884554
   PubMed Web of Science ®Google Scholar
• GoldstrawPIASLC Staging Manual in Thoracic OncologyOrange Park, FLEditorial Rx Press John Wiley & Sons Ltd2009
   Google Scholar
• GoldstrawPThe 7th Edition of TNM in Lung Cancer: what now?J Thorac Oncol20094667167319461399
   PubMed Web of Science ®Google Scholar
• TravisWDBrambillaEMüller-HermelinkHKHarrisCCWorld Health Organization Classification of Tumors Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and HeartLyon, FranceIARC Press2004
   Google Scholar
• TravisWDBrambillaENoguchiMInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaJ Thorac Oncol20116224428521252716
   PubMed Web of Science ®Google Scholar
• TantraworasinASaetengSLertprasertsukeNArreyakajohnNKasemsarnCPatumanondJPrognostic factors of tumor recurrence in completely resected non-small cell lung cancerCancer Manag Res20135778423785244
   PubMedGoogle Scholar
• VilmarACSantoni-RugiuESørensenJBERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trialAnn Oncol20102191817182420332140
   PubMed Web of Science ®Google Scholar
• TepeliECanerVBüyükpınarbaşılıNExpression of ERCC1 and its clinicopathological correlations in non-small cell lung cancerMol Biol Rep201239133534121553054
   PubMed Web of Science ®Google Scholar
• PestaMKuldaVFialaOPrognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancerAnticancer Res201232115003501023155271
   PubMed Web of Science ®Google Scholar
• OlaussenKADunantAFouretPIALT Bio InvestigatorsDNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyN Engl J Med20063551098399116957145
   PubMed Web of Science ®Google Scholar
• LeeKHMinHSHanSWERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancerLung Cancer200860340140718036700
   PubMed Web of Science ®Google Scholar
• BeplerGOlaussenKAVataireALERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysisAm J Pathol20111781697821224045
   PubMed Web of Science ®Google Scholar
• CustodioABGonzález-LarribaJLBobokovaJPrognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancerJ Thorac Oncol20094789191019433989
   PubMed Web of Science ®Google Scholar
• BootonRWardTAshcroftLMorrisJHeighwayJThatcherNERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancerJ Thorac Oncol200721090290617909351
   PubMed Web of Science ®Google Scholar
• RothJACarlsonJJPrognostic role of ERCC1 in advanced non-small-cel lung cancer: a systematic review and meta-analysisClin Lung Cancer201112639340121723790
   PubMed Web of Science ®Google Scholar
• FribouletLOlaussenKAPignonJPERCC1 isoform expression and DNA repair in non-small-cell lung cancerN Engl J Med2013368121101111023514287
   PubMed Web of Science ®Google Scholar
• WintonTLivingstonRJohnsonDNational Cancer Institute of Canada Clinical Trials Group: National Cancer Institute of the United States Intergroup JBR 10 Trial Investigators. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancerN Engl J Med2005352252589259715972865
   PubMed Web of Science ®Google Scholar
• PignonJPTribodetHScagliottiGVLung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin OncolJul 202008262135523559
   Google Scholar
• BeplerGGautamAMcIntyreLMPrognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancerJ Clin Oncol20022051353136011870179
   PubMed Web of Science ®Google Scholar
• GautamALiZRBeplerGRRM1-induced metastasis suppression through PTEN-regulated pathwaysOncogene200322142135214212687015
   PubMed Web of Science ®Google Scholar
• BeplerGSharmaSCantorARRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancerJ Clin Oncol200422101878188515143080
   PubMed Web of Science ®Google Scholar
• BeplerGWilliamsCSchellMJRandomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancerJ Clin Oncol201331192404241223690416
   PubMed Web of Science ®Google Scholar
• GongWZhangXWuJRRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysisLung Cancer201275337438021889227
   PubMed Web of Science ®Google Scholar
• ZhengZChenTLiXHauraESharmaABeplerGDNA synthesis and repair genes RRM1 and ERCC1 in lung cancerN Engl J Med2007356880080817314339
   PubMed Web of Science ®Google Scholar